详情页 - 四川省肿瘤医院知识库

当前位置：首页 > 详情页

Ferroptosis-related ACSL3 and ACTC1 predict metastasis free survival for prostate cancer patients undergoing radical radiotherapy

文献详情

资源类型：

Pubmed体系：

作者：

机构： [1]Department of Urology, Institute of Urology, West China Hospital, Sichuan University, Chengdu, 610041, China.

出处：

DOI：

ISSN：

关键词： Ferroptosis Prostate cancer Tumor immune microenvironment Biochemical recurrence Metastasis

语种：

PubmedID：

中科院(CAS)分区：

出版当年[2022]版：

大类 | 3 区医学

小类 | 3 区外科

最新[2023]版：

大类 | 3 区医学

小类 | 3 区外科

第一作者：

第一作者机构： [1]Department of Urology, Institute of Urology, West China Hospital, Sichuan University, Chengdu, 610041, China.

通讯作者：

通讯机构： [1]Department of Urology, Institute of Urology, West China Hospital, Sichuan University, Chengdu, 610041, China. [*1]Department of Urology, Institute of Urology, West China Hospital, Sichuan University, Guoxue Xiang #37, Chengdu, 610041, Sichuan, People's Republic of China.

推荐引用方式(GB/T 7714)：

APA：

MLA：

相关文献

[1]An autophagy-related gene prognostic index predicting biochemical recurrence, metastasis, and drug resistance for prostate cancer [2]Mitochondrial Aldehyde Dehydrogenase 2 Represents a Potential Biomarker of Biochemical Recurrence in Prostate Cancer Patients [3]A cellular senescence-related gene prognostic index for biochemical recurrence and drug resistance in patients with prostate cancer [4]Establishment of novel ferroptosis-related prognostic subtypes correlating with immune dysfunction in prostate cancer patients [5]A Ferroptosis-Related Gene Prognostic Index Associated With Biochemical Recurrence and Radiation Resistance for Patients With Prostate Cancer Undergoing Radical Radiotherapy. [6]A Novel Four Mitochondrial Respiration-Related Signature for Predicting Biochemical Recurrence of Prostate Cancer [7]A Gene Prognostic Index Associated With Epithelial-Mesenchymal Transition Predicting Biochemical Recurrence and Tumor Chemoresistance for Prostate Cancer. [8]A gene prognostic index from cellular senescence predicting metastasis and radioresistance for prostate cancer. [9]Transurethral resection of the prostate is an independent risk factor for biochemical recurrence after radical prostatectomy for prostate cancer. [10]Evaluation of 18F-PSMA-1007 PET/CT in prostate cancer patients with biochemical recurrence after radical prostatectomy.